IRADIMED CORP Quarterly Selling and Marketing Expense in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Iradimed Corp quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2013 to Q2 2024.
  • Iradimed Corp Selling and Marketing Expense for the quarter ending June 30, 2024 was $3.48M, a 17.9% increase year-over-year.
  • Iradimed Corp Selling and Marketing Expense for the twelve months ending June 30, 2024 was $12.7M, a 21.6% increase year-over-year.
  • Iradimed Corp annual Selling and Marketing Expense for 2023 was $12.1M, a 4.24% decline from 2022.
  • Iradimed Corp annual Selling and Marketing Expense for 2022 was $12.7M, a 20.1% increase from 2021.
  • Iradimed Corp annual Selling and Marketing Expense for 2021 was $10.6M, a 3.91% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $12.7M $3.48M +$528K +17.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $12.2M $821K +$27.3K +3.44% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $12.1M $5.54M +$1.87M +51% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $10.3M $2.86M -$173K -5.69% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $10.4M $2.95M +$40.6K +1.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $10.4M $794K -$2.28M -74.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $12.7M $3.67M +$544K +17.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $12.1M $3.04M +$452K +17.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $11.7M $2.91M +$438K +17.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $11.2M $3.07M +$690K +29% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $10.6M $3.12M +$52.4K +1.71% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $10.5M $2.59M +$303K +13.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $10.2M $2.47M +$95.6K +4.03% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $10.1M $2.38M -$54.4K -2.24% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $10.2M $3.07M +$507K +19.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-04
Q3 2020 $9.65M $2.28M -$14.5K -0.63% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $9.67M $2.37M +$174K +7.92% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $9.49M $2.43M +$323K +15.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $9.17M $2.56M +$513K +25% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-04
Q3 2019 $8.66M $2.3M +$513K +28.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $8.14M $2.2M +$684K +45.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $7.46M $2.11M +$465K +28.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $7M $2.05M +$486K +31.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-05
Q3 2018 $6.51M $1.78M +$533K +42.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $5.98M $1.52M +$193K +14.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $5.78M $1.65M +$281K +20.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $5.5M $1.56M +$324K +26.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-06
Q3 2017 $5.18M $1.25M -$94.8K -7.04% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $5.27M $1.32M -$86.2K -6.12% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $5.36M $1.36M +$81.7K +6.37% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $5.28M $1.24M -$67.5K -5.17% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $5.35M $1.35M +$141K +11.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $5.21M $1.41M +$305K +27.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $4.9M $1.28M +$194K +17.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $4.71M $1.31M +$514K +64.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $4.19M $1.21M +$325K +37% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $3.87M $1.1M +$240K +27.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $3.63M $1.09M +$329K +43.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $3.3M $792K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 $881K +$367K +71.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $865K +$369K +74.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $760K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 $514K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $496K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.